about
Saci-1, -2, and -3 and Perere, four novel retrotransposons with high transcriptional activities from the human parasite Schistosoma mansoniSchistosoma mansonivenom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifsA quantitative view of the transcriptome of Schistosoma mansoni adult-worms using SAGEStage and tissue expression patterns of Schistosoma mansoni venom allergen-like proteins SmVAL 4, 13, 16 and 24.Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.Induction of boosted immune response in mice by leptospiral surface proteins expressed in fusion with DnaK.The contribution of 700,000 ORF sequence tags to the definition of the human transcriptome.Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in BrazilSchistosome transcriptome: insights and perspectives for functional genomics.The Schistosome Esophagus Is a 'Hotspot' for Microexon and Lysosomal Hydrolase Gene Expression: Implications for Blood ProcessingNew Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial PromotersVaccines of the Future: The Role of Inflammation and AdjuvanticityFusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.Schistosomiasis--a century searching for chemotherapeutic drugs.Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine productionImmunization with tegument nucleotidases associated with a subcurative praziquantel treatment reduces worm burden following Schistosoma mansoni challenge.Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune responseRecombinant vaccines and the development of new vaccine strategies.Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.Advocacy, partnership and political commitment for TB vaccine research.Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.Recombinant BCG Expressing LTAK63 Adjuvant induces Superior Protection against Mycobacterium tuberculosis.Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer.A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice.A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy.IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.Proliferation of mouse fibroblasts induced by 1,2-dimethylhydrazine auto-oxidation: role of iron and free radicals.Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability.Schistosoma mansoni venom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifs. Corrigendum.Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates.Sm21.6 a novel EF-hand family protein member located on the surface of Schistosoma mansoni adult worm that failed to induce protection against challenge infection but reduced liver pathology.Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei.Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
P50
Q24633915-9D22A0F6-AF52-4C7F-B60C-78B0C5D59C31Q27684904-66BB206C-EA9E-44B6-948C-47915230A3ECQ33288488-0D11C496-9425-4D05-8196-3359E2A9A9A5Q33651570-10E2E1B7-4A30-4D57-9991-D1720BF3C659Q33725192-AECA1B0D-EA48-47F3-9FA5-10121814F5D7Q33944432-7FFBA6C8-B76B-432F-A24D-F5697AAF5565Q33947020-481944AE-D73C-473A-B42B-EAB143148D65Q34130636-FB9D8CD0-F0A3-4409-A5BE-2B18B5DF8447Q35037028-0AC9B1D7-21D5-4181-B8C0-FC5B4BCA6140Q35073127-C99D3232-F7A6-4B45-B0EF-61699B8DE8D9Q35802864-FF32D1A1-9C87-457E-A531-0A4AFF41E005Q35862448-8A1D4FF4-5E5C-482C-8E8B-C2EBF87A045CQ35916250-5032A43A-5E33-4492-9DBE-D57D656CD14FQ36038567-543F999D-43BD-4D3B-9746-5260DAD1E124Q36314000-B41CE762-CB1D-4FCF-A443-60E283FBF8FCQ36459174-97E3208C-C90D-4391-A1E5-166C4AC883F3Q36497698-2B6EADA7-DF97-43E3-8BE5-0229EF56682CQ36772127-4508EA7B-C38F-4AA0-B4BB-65FA47FD7FD1Q36911270-E27B698A-9CE8-4BED-96A1-A93C844B02A7Q37370940-736AECCA-DDD6-43EC-9760-8383A7E59BA6Q38100039-63523660-0F01-466E-B979-D1F2D1B8D061Q38668300-C3CFD336-5555-4A86-B0A9-F33A98AB724EQ38842916-1BA76CFF-F370-49DE-9E7C-A0677C0B5A69Q39164566-72FB5633-D460-49C4-A577-71466BBEF76CQ39294350-FD174CFD-0D64-4D26-A999-ECFC885F02F6Q39518278-6D5CD263-098C-42AD-A937-9F1E171CD358Q39875256-4EA40E45-7D3E-4CF8-9F07-BF1D8A82CE8DQ40089381-BD45DFA6-DE8E-44F1-956B-0CFFD6A858B3Q40109570-626C98E3-79C4-4C66-A59D-6E6569C44532Q40315728-6372B87D-D2CF-40AA-8347-8F59098A732DQ40345279-DF76C8BB-375B-483D-8B13-00C73CEFF1A7Q41110759-60E778DC-B11F-483F-95CE-D6B526706B77Q41461047-9241A03C-89BC-4F32-B564-EE6263A4D805Q42236653-2C66B26F-0AFD-4958-83A4-6A7293FCBCBAQ43098224-EA322121-4D29-4393-AD3F-2C2613A05E1FQ43271063-7D141425-8018-4AA6-9DA1-3127B5E7129AQ44205120-44FDF28F-A23E-492A-ABF9-C6BCB21857ACQ44540371-04162C02-2D1E-415D-9249-26EEDA6B262FQ44624566-5B9C8967-A07D-455B-88BD-4DA91057BB4BQ44700058-8629FEC2-9DC8-4CEE-87FF-181D85637B87
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
L C Leite
@ast
L C Leite
@en
L C Leite
@es
L C Leite
@nl
type
label
L C Leite
@ast
L C Leite
@en
L C Leite
@es
L C Leite
@nl
prefLabel
L C Leite
@ast
L C Leite
@en
L C Leite
@es
L C Leite
@nl
P31
P496
0000-0003-0156-1312